Osimertinib Mesylate Tablets: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| NSCLC Patients With Brain Metastasis | 1 |
| Non-small Cell Lung Cancer | 1 |
Recruiting trials involving Osimertinib Mesylate Tablets
- A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases
- A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Common questions
How many recruiting trials involve Osimertinib Mesylate Tablets?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.